By analyzing cancer and neuronal cell models, we find that compromising ATXN3 function leads to a severe delay in clearing and regenerating damaged lysosomes and thus in restoring functionality of the lysosomal system after lysosomal damage. The gene discussed is ATXN3; the disease is cancer.